KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Science Applications International (SAIC) Cash & Equivalents (2016 - 2026)

Science Applications International (SAIC) has disclosed Cash & Equivalents for 13 consecutive years, with $45.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 2.17% year-over-year to $45.0 million, compared with a TTM value of $45.0 million through Oct 2025, down 2.17%, and an annual FY2025 reading of $56.0 million, down 40.43% over the prior year.
  • Cash & Equivalents was $45.0 million for Q4 2025 at Science Applications International, down from $48.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $422.0 million in Q2 2023 and bottomed at $45.0 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $132.7 million, with a median of $96.5 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents surged 653.57% in 2023, then tumbled 88.39% in 2024.
  • Year by year, Cash & Equivalents stood at $148.0 million in 2021, then plummeted by 64.19% to $53.0 million in 2022, then skyrocketed by 486.79% to $311.0 million in 2023, then plummeted by 85.21% to $46.0 million in 2024, then dropped by 2.17% to $45.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for SAIC at $45.0 million in Q4 2025, $48.0 million in Q3 2025, and $47.0 million in Q2 2025.